Delivery Order SPE2DB25D9756-SPE2DB25FTKYA
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on June 2, 2025, with a ceiling value of $20,085.04. The contract calls for the delivery of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials, a long-acting local anesthetic used in surgical and medical settings. The award carries no set-aside designation and is scheduled for ultimate completion...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 27, 2025, for EXPAREL 266 mg/20 ml vials valued at $10,042.52. This firm fixed-price delivery order, which has a completion date of September 18, 2025, was issued without a set-aside designation. The award represents a single delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of EXPAREL 133 mg/10 ml vials. The contract is valued at $1,507.22 under a firm fixed-price arrangement with an ultimate completion date of May 15, 2025. This delivery order was issued without set-aside designation, leveraging the vendor's competitive position as a woman-owned...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 3, 2025, for EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials. This firm fixed-price delivery order carries a ceiling value of $37.4K and represents a task order under the company's larger Indefinite Delivery Contract with DLA valued at $500M through November 2026. The contract requires ultimate...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $8,234.32 by the Defense Logistics Agency (DLA) for the supply of EXPAREL 266 mg/20 ml vials. The award, issued on May 20, 2025, with an ultimate completion date of June 11, 2025, operates under a firm fixed-price contract type with no set-aside designation. EXPAREL is a liposomal bupivacaine formulation used for prolonged local...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency valued at $16,071.40 for EXPAREL 266 mg/20 ml vials. The contract, awarded on July 14, 2025, with an ultimate completion date of August 4, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $25,106.30 firm fixed-price delivery order by the Defense Logistics Agency on August 14, 2025, for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials. The contract carries an ultimate completion date of September 5, 2025, and involves no set-aside designation. This delivery order represents a continuation of DMS Pharmaceutical Group's substantial role...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 11, 2025, by the Defense Logistics Agency (DLA) for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, valued at $7,531.89 with an ultimate completion date of September 2, 2025, represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on July 24, 2025, for the supply of EXPAREL 266 mg/20 mL vials. This firm fixed-price delivery order, valued at $50,212.60, is set to be completed by August 14, 2025, with performance taking place at the company's Park Ridge location. The award carries no set-aside designation, reflecting the contractor's competitive...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. The contract is a firm fixed-price delivery order with a ceiling value of $12,553.15 and an ultimate completion date of August 4, 2025. This award was made without a set-aside designation, and the place of performance is Park Ridge, Illinois. DMS Pharmaceutical Group is...
- SPE2DB25D9756Indefinite Delivery Contract
- SPE2DB25D9756-SPE2DB25FTKYADelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on July 24, 2025, for EXPAREL 133 mg/10 mL vials. The contract is valued at $1,707.02 and is classified as a firm fixed-price delivery order with an ultimate completion date of August 14, 2025. The award carries no set-aside designation, and the place of performance is located in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide. EXPAREL is a liposomal bupivacaine product used for surgical anesthesia and post-operative pain management in military medical settings. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a robust portfolio of contracts delivering branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. The company's consistent success in securing contracts reflects its competitive positioning as a woman-owned small business capable of meeting the DLA's pharmaceutical distribution requirements across its global network of military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/24/25 |